INNOVATE is a diversified holding company operating across three segments: Infrastructure, Life Sciences, and Spectrum. The Infrastructure segment, operated through subsidiary DBMG Global, is the dominant business, generating the vast majority of consolidated revenue. DBMG is a fully integrated structural steel contractor that fabricates and erects structural steel for large commercial and industrial projects — including data centers, stadiums, hospitals, and manufacturing plants — for general contractors, engineering firms, and industrial owners across the U.S. and internationally. DBMG operates 12 fabrication shops and five business units, the largest being Schuff Steel Company. DBMG wins work through competitive bids and negotiated contracts, earning revenue on fixed-price, cost-plus, and time-and-material structures. The Life Sciences segment, Pansend, is a portfolio of early-stage healthcare companies: R2 Technologies sells aesthetic skin-cooling devices to medical practices and aestheticians, while MediBeacon recently received FDA approval for a transdermal kidney function monitoring device. The Spectrum segment operates 257 over-the-air broadcast TV stations across the U.S., leasing airtime to third-party content networks. INNOVATE is currently under debt-covenant pressure that has forced it to commence formal sale processes for both the Infrastructure and Spectrum segments, with management indicating that the company's future focus, following those divestitures, will center on its Life Sciences businesses.